Articles

The custom chip maker added a fourth customer that is expected to deliver $10 billion in revenue, and Mizuho analysts believe it could be OpenAI rival Anthropic.

Almost all health-insurance claim denials go uncontested, but an AI solution is like “TurboTax for appeals,” one company’s expert says.

Tesla will be riding one of its strongest delivery periods in history but will also have to face questions about its future in autonomy.

A J.P. Morgan analyst downgrades Goldman Sachs to neutral from overweight, saying Barclays and Deutsche Bank offer more potential upside.

Experts warn that stolen jewelry finds its way into the mainstream market all the time, so buyer beware.

Ozempic maker Novo Nordisk is shaking up its board.

Price increases offset flat sales in certain business units.

GM doesn’t anticipate tariff costs to be as steep as it previously expected. The automaker is also benefiting from higher prices, and says its move to trim EV production will pay off next year.

BLS’s September inflation report will set Social Security’s 2026 cost-of-living adjustment.

A panel discussion at the recent J.P. Morgan/Robinhood Investors Conference offered up ideas for some important AI investments investors should be looking at now.

If China’s demand slows, gold’s price will decline. Much is riding on U.S.-China politics.

GE Aerospace shares rallied into record territory after a big earnings beat and a raised full-year outlook.